Harald Hampel
Physiology · 2003–2021
A researcher in the Science corpus: 24 papers; trusts 10 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 350 citations into it; #230 of 2,276 by trust here, #33 by citations
- Psychiatry and Mental health — 240 citations into it; #211 of 1,338 by trust here, #61 by citations
- Molecular Biology — 163 citations into it
- Cognitive Neuroscience — 74 citations into it; #4,905 of 10,852 by trust here, #1,946 by citations
- Radiology, Nuclear Medicine and Imaging — 47 citations into it; #1,256 of 3,265 by trust here, #861 by citations
- Pharmacology — 37 citations into it; #282 of 1,112 by trust here, #150 by citations
- Artificial Intelligence — 10 citations into it
- Computer Vision and Pattern Recognition — 9 citations into it
Whom Harald Hampel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Selkoe
- Kaj Blennow
- Karl J. Friston
- Clifford R. Jack Jr.
- Rachael I. Scahill
- John Ashburner
- Reisa A. Sperling
- Vladimir Naumovich Vapni
- H. Braak
- Susanne G. Mueller
Who trusts Harald Hampel overall
- Michael G. Erkkinen
- Kaj Blennow
- Clifford R. Jack Jr.
- Henrik Zetterberg
- Bruno Dubois
- Oskar Hansson
- Mee‐Ohk Kim
- I. Hamley
- Lennart Minthon
- Yong He
Papers from Harald Hampel's perspective
Ordered by how strongly the researchers Harald Hampel trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
- Voxel-based morphometry--the methods.
- Current concepts in mild cognitive impairment. (Archives of Neurology)
- An Information-Maximization Approach to Blind Separation and Blind Deconvolution
- Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) (Alzheimer's & Dementia)
- The pathological process underlying Alzheimer’s disease in individuals under thirty (Acta Neuropathologica)
- Measuring the thickness of the human cerebral cortex from magnetic resonance images. (Proceedings of the National Academy of Sciences of the United States of America)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline (Nature)
Their papers
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (2010) — 659 citations
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) — 1,794 citations
- Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) — 1,585 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- The Amyloid-β Pathway in Alzheimer’s Disease (2021) — 1,619 citations
- The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. (2018) — 1,488 citations
- Sex differences in Alzheimer disease — the gateway to precision medicine (2018) — 868 citations
- Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria (2016) — 1,741 citations
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) — 1,607 citations
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. (2014) — 3,079 citations
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) — 1,239 citations
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) — 1,348 citations
- Variant of TREM2 Associated with the Risk of Alzheimer’s Disease (2012) — 2,442 citations
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) — 1,932 citations
- Revising the definition of Alzheimer's disease: a new lexicon. (2010) — 1,937 citations
- Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease (2010) — 356 citations
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) — 635 citations
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease (2010) — 1,879 citations
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (2009) — 1,205 citations